Lucid Diagnostics Inc.(NasdaqGM:LUCD) dropped from Russell 3000E Value Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6707 USD | +0.09% | -15.79% | -52.43% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.43% | 32.33M | |
+72.43% | 12.34B | |
-18.96% | 7.96B | |
+16.09% | 7.16B | |
+4.81% | 5.72B | |
+6.51% | 5.03B | |
+27.07% | 4.35B | |
-21.67% | 3.99B | |
-40.87% | 2.21B | |
+1.49% | 2.01B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Lucid Diagnostics Inc.(NasdaqGM: LUCD) dropped from Russell 3000E Value Index